Enzo Life Sciences SuperFasLigand for enhanced immune activation

Friday, 17 October, 2014 | Supplied by: United Bioresearch Products Pty Ltd

The critical role of signals transmitted via TNF ligands and receptors in mediating inflammation, cancer and immunity are well established. Recombinant TNF ligands can be used in drug development to enhance immune activation. Oligomerisation of TNF ligands using enhancers and expression of self-oligomerising chimeric proteins have been shown to improve stability and significantly enhance immune activation compared to that achieved with recombinant ligands alone.

SuperFasLigand is soluble, human and recombinant. It is said to provide enhanced immune activation compared to other recombinant ligands. The product features an N-terminus linker shown to improve stability and mimics glycosylation of native human FasL.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309
Related Products

Lonza 4D-Nucleofector LV Unit PRO electroporation unit

Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...

Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)

The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...

Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms

The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...

Content from other channels on our network

No More Blockages for Western Sydney Meat Works after Gorman-Rupp Pump Upgrade

Taking the electronic pulse of the circular economy

Radio station set to reduce emissions by 25%

New firming tender to protect NSW's energy security

Council provides rebates to improve energy efficiency

New Report Reveals Next-Gen Tech Driving Major Growth in Australian Food Processing

Energy-efficient plate freezing: No longer just for the big players

Energy Management in Manufacturing: One System Doesn't Fit All

Making the invisible visible

Brewing up a novel pet food using precision fermentation

Solving the hospital kitchen hygiene challenge

In Conversation with Australia's Chief Medical Officer, Professor Michael Kidd AO

What sets Supagas apart in delivering medical gases?

Group Captain Kath Stein FACN GAICD becomes ACN president

ACSQHC unveils first new brand and 2025–30 strategic plan

  • All content Copyright © 2025 Westwick-Farrow Pty Ltd